Full View

Rifampin pharmacokinetics and safety in preterm and term infants

PB Smith, CM Cotten, ML Hudak… - Antimicrobial Agents …, 2019 - Am Soc Microbiol
Rifampin is active against methicillin-resistant staphylococcal species and tuberculosis (TB).
We performed a multicenter, prospective pharmacokinetic (PK) and safety study of …
被引用次数：11 相关文章

Rifampin Pharmacokinetics and Safety in Preterm and Term Infants

PB Smith, CM Cotten, ML Hudak… - Antimicrobial …, 2019 - pubmed.ncbi.nlm.nih.gov
Rifampin is active against methicillin-resistant staphylococcal species and tuberculosis (TB).
We performed a multicenter, prospective pharmacokinetic (PK) and safety study of …
[HTML] nih.gov

[HTML][HTML] Rifampin Pharmacokinetics and Safety in Preterm and Term Infants

PB Smith, CM Cotten, ML Hudak… - Antimicrobial Agents …, 2019 - ncbi.nlm.nih.gov
Rifampin is active against methicillin-resistant staphylococcal species and tuberculosis (TB).
We performed a multicenter, prospective pharmacokinetic (PK) and safety study of …

Rifampin pharmacokinetics and safety in preterm and term infants.

PB Smith, CM Cotten, ML Hudak, JE Sullivan… - 2019 - cabidigitallibrary.org
Rifampin is active against methicillin-resistant staphylococcal species and tuberculosis (TB).
We performed a multicenter, prospective pharmacokinetic (PK) and safety study of …

Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.

PB Smith, CM Cotten, ML Hudak… - Antimicrobial Agents …, 2019 - europepmc.org
Rifampin is active against methicillin-resistant staphylococcal species and tuberculosis (TB).
We performed a multicenter, prospective pharmacokinetic (PK) and safety study of …